IAK (IAK) Stock Price & Analysis
IAK (IAK) rose 2.11% to USD 148.15 as of July 25, 2026 at 14:23 UTC, according to Nexqual real-time market data.
IAK last closed at USD 145.09; the session ranged USD 145.43–148.27 on volume of 78,110 shares. Market capitalization is —, with a 52-week range of USD 124.62–150.18 (PCX). Source: Nexqual, July 25, 2026 at 14:23 UTC.
Key Statistics (as of July 25, 2026 at 14:23 UTC)
| Price | USD 148.15 |
|---|---|
| Change | ▲ 2.11% (up) |
| Previous Close | USD 145.09 |
| Open | USD 145.27 |
| Day Range | USD 145.43 – 148.27 |
| 52-Week Range | USD 124.62 – 150.18 |
| Volume | 78,110 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IAK)
Nexqual's technical model rates IAK "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 14:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.51 (neutral) |
| vs SMA50 | Above (USD 137.91) |
| MACD | 2.3 (positive) |
Financial Health Score (IAK)
Nexqual rates IAK's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 14:23 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IAI | iShares U.S. Broker-Dealers & S | USD 186.9 | ▼ 1.53% |
| KIE | State Street SPDR S&P Insurance | USD 64.14 | ▲ 2.25% |
| IAT | iShares U.S. Regional Banks ETF | USD 63.74 | ▼ 0.28% |
| IYG | iShares U.S. Financial Services | USD 94.47 | ▲ 0.1% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.38 | ▲ 1.73% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 14:23 UTC. This page is informational and not investment advice.